参考文献 References
[1] 刘玉娥,刘继兰,曹中兴.大环内酯类抗生素的研究进展[J].中华医院感染学杂志,2003,04:99-101.
[2] 周艳春,赵燕燕.大环内酯类抗生素非抗菌作用研究进展[J]．山西医药杂志，2016,60(9):1034-1037.
[3] 黄允省.大环内酯类抗生素的研究新进展[J].临床合理用药，2018,11(9):164-165.
[4] 李喆宇,崔玉彬,张静霞,唐克慧.大环内酯类抗生素的研究新进展[J].国外医药(抗生素分册),2013,34(01):6-15.
[5] Khaleda H. Al-Saidi, Hayder Q. Munshid. New polymeric membrane electrode for clarithromycin determination [J]. J N U, 2013, 16 (2): 30-36.
[6] 汤雨晴,叶倩,郑维义.抗生素类药物的研究现状和进展[J].国外医药(抗生素分册),2019,40(04):295-301.
[7] 朱静,徐彦贵,高仲阳,克拉霉素的药理特性及应用[J].中国医院药学杂志,2001,09:39-41.
[8] 张卫东,季连姚,克拉霉素的药理作用及临床应用[J].黑龙江医药,2005,06:438-439.
[9] Thakur K, Meenu Nagpal, Geeta Aggavwal. Development and evaluation of solid dispersion using binary and ternary complexes [J]. Depart Pharmaceut, 2014, 2(8):1793-1812.
[10] Rahul S, Rajashree Masareddy, Nagesh C. Formulation and evaluation of clarithromycin pooly soluble drug as microemulsion [J]. Int Res J Pharm, 2011, 2(11): 153-158.
[11] 邹达亮,张佳,糜志远.克拉霉素制剂研究应用进展[J].中国医院药学杂志,2016,36(24):2222-2225.
[12] J.G.-B. Evangelos, Macrocycle Molecules for the Management of Systemic Infections: the Clarithromycin Paradigm[J]. Current Topics in Medicinal Chemistry, 2010, 14 (10): 1470-1475.
[13] 曲艳杰,高淑青,王艳,郝美丽.对比克拉霉素(口服)、红霉素(静滴)对小儿呼吸道支原体感染的临床疗效[J].临床医药文献电子杂志,2017,13(4): 2546-2550.
[14] 王慧玲.克拉霉素治疗老年人下呼吸道感染70例[J].医学理论与实践,2001(11):1126-1127.
[15] 匡庆贵,付印强,陈顼,赵正秋.克拉霉素对儿童咳嗽变异性哮喘气道炎症的影响及疗效分析[J].临床肺科杂志,2015,06(20):1095-1099.
[16] 欧相林,黄江,曾祥毅,长期小剂量克拉霉素对稳定期慢性阻塞性肺疾病的疗效观察[J].实用医学杂志,2006,13:1558-1559.
[17] 汪坤.克拉霉素、阿莫西林联合甲硝唑治疗幽门螺杆菌相关性皮肤病的效果研究[J].当代医药论丛,2017,11(15):114-115.
[18] T. C, P. A, M. G C, Clarithromycin versus doxycycline in the treatment of rosacea [J]. Int. J. Dermatol., 1997, 36(12): 942-946.
[19] 王丽君. 口服克拉霉素联合颠倒散洗剂外用治疗寻常性痤疮的临床疗效观察[D], 南京中医药大学, 2014.
[20] 李党坚,苏高叶,黄月桂.兰索拉唑联合克拉霉素治疗幽门螺杆菌感染性胃病的效果及不良反应[J]. 深圳中西医结合杂志,2018,12(28):119-121.
[21] 葛涵，沈舜义.大环内酯类抗生素研究进展［J］．世界临床药物,2007，28(6):376-380.
[22] Vemura N, Mukai T, Okamoto S, et al. Effect of helicrobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric canycer [J]. Cancer Epid Biomar Prey, 1997, 6(8): 639.
[23] Y. Teng, Y. Qin, D. Song, X. Liu, Y. Ma, P. Zhang, S. Ma, A novel series of 11-O-carbamoyl-3-O-descladinosyl clarithromycin derivatives bearing 1,2,3-triazole group: Design, synthesis and antibacterial evaluation [J]. Bioorganic & Medicinal Chemistry Letters, 2020, 2(30): 126850.